teriparatide

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions:   

Frequency defined 

>10%  

Arthralgia (10.1%)  

Pain (21.3%)  

1-10%  

Dizziness (8%)  

Headache (7.5%)  

Rhinitis (9.6%)  

Asthenia (8.7%)  

Pneumonia (3.9%)  

Vertigo (3.8%)  

Nausea (8.5%)  

Hypertension (7.1%)  

Increased cough (6.4%)  

Pharyngitis (5.5%)  

Diarrhea (5.1%)  

Rash (4.9%)  

Insomnia (4.3%)  

Angina pectoris (2.5%)  

Gastrointestinal disorder (2.3%)  

Tooth disorder (2%)  

Depression (4.1%)  

Constipation (5.4%)  

Dyspepsia (5.2%)  

Dyspnea (3.6%)  

Neck pain (3%)  

Vomiting (3%)  

Syncope (2.6%)   

Leg cramps (2.6%)  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:     

AU TGA pregnancy category: B3
US FDA pregnancy category: Not assigned 

Lactation: 

Excreted into human milk is Unknown 

Pregnancy Categories:       

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.       

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women       

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women       

Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.       

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.       

Category N: There is no data available for the drug under this category 

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet    

Generic Name: teriparatide  

Why do we use teriparatide? 

teriparatide is a Parathyroid Hormone Analogs used to treat osteoporosis.